Author, date and country | Patient group | Study type (level of evidence) | Outcomes | Key results | Study Weaknesses |
---|---|---|---|---|---|
Askar FZ, et al. 2007 USA | 33 patients undergoing thoractomy randomised into 2 groups: The IV PCA morphine and intrathecal morphine group (n=17) and control group (IV PCA morphine only) (n=16). | 1b - prospective randomised clinical trial | Post-operative VAS pain score | Reduced at rest, while coughing and while moving at 4 hours, 24 hours and 48 hours in the intrathecal morphine group (all p<0.01) | Small patient numbers meaning results may not be suitably reliable to draw firm conclusions from. The randomisation was not blinded and so may have had an impact by introcuding error. The patients were undergoing a heterogenous group of operations, which may have impacted on pain scores as the operations were not matched between groups. |
Peak expiratory flow rate (PEFR) | The best PEFR scores were 72% of pre-operative level in the intrathecal group and 61% in the control group (p<0.05) | ||||
Morphine demand | Lower in intrathecal morphine group (8.82 (+/-6.82) mg) than non-intrathecal group (20.12 (+/- 15.78) mg) (p<0.05) | ||||
Post-operative sedation | Higher in the intrathecal morphine group at 10 and 30 minutes post-operative (p<0.05), but lower at 24 hours post-operation (p<0.05) | ||||
Mean arterial pressure | No significant difference | ||||
Heart rate | No significant difference | ||||
Respiratory rate | No significant difference | ||||
Liu N, et al. 2001 France | 50 patients in total. 20 control patients receiving on IV PCA morphine. 10 patients each in the groups: Intrathecal morphine (group M), intrathecal sufentanil (group S), or intrathecal morphine and sufentanil (group M-S). | 1b - prospective randomised double-blinded study | Post-operative IV PCA morphine usage | Higher in control group (71 +/- 30 mg) compared to group M (38 +/-31 mg, p<0.05), group S (46 +/-34 mg, p<0.05), and group S-M (23 +/-16 mg, p<0.01). | No use of a true placebo group (e.g. intrathecal saline injection). Only one dose of each of the drugs was used, so not able to distinguish between additive and supraadditive effect. |
Post-operative VAS pain score | Higher in control group than all three intervention groups at rest for first 0-11 hours post-operation (p<0.05 for all comparisons) and on coughing for the first 0-8 hours post-operation (p<0.05 for all comparisons). | ||||
Cohen E, et al. 1993 USA | 24 patients, 12 received intrathecal injection of 12 micrograms/kg morphine sulphate, the remaining 12 acted as controls. Anaesthesia was maintained solely by enflurane for all patients, titrated to keep mean arterial pressure within 15% of the preoperative values. | 2b - Individual randomised control trial. | Intraoperative mean end-tidal volume concentration of enflurane | Significantly reduced in the group receiving intrathecal morphine (0.73 +/- 0.08%) than the control group (1.19 +/- 0.45%) (p<0.05) | The number of patients was relatively low. The method of randomisation was not mentioned. The patients were randomised, but the researchers were not blinded to groups. The post-operative aspects of the intrathecal morphine were not investigated in this paper. Other parameters other than enflurane requirements were not measured. |
Neustein SM, et al. 1993 USA | 30 patients, 16 received 12 micrograms/kg of intrathecal morphine, the remaining 14 patients were controls. | 1b - Individual randomised control trial. | Post-operative VAS pain score | Those receiving intrathecal morphine had lover pain scores (1.4 +/- 1.1) than controls (2.4 +/- 0.9) (p<0.05). | The number of patients was relatively low. The method of randomisation was not mentioned. The patients were randomised, but the researchers were not blinded to the groups. |
Total 24 hour dose of meperidine | Those receiving intrathecal morphine used significantly less meperidine (59 +/- 68 mg) compared to controls (167 +/- 97 mg) (p<0,05). |